 |
|
 |
- November 20, 2008 |
|
|
Welcome to the #1 online source of information for Diabetes Specialists! An international online community of more than 10,000 Diabetes Specialists.
CME on Diabetes is a website built to transmit top-level CME conferences given by international experts in endocrinology, insulin resistance, prediabetes, metabolic syndrome and type 2 diabetes. More than 2.6 million slides have been viewed since the website launch. Thank you for your continued support and commitment!
|
|
|
| Presentation |
|
"Where Do Glitazones Fit In in clinical practice?"Dr. Soji Swaraj (biography)
English - 2007-11-10 - 39 minutes
|
 | (39 slides) |
Summary :
In this presentation Dr. Swaraj discusses the use of glitazones in diabetes treatment. Many treatment options are available and it is important to understand the place of each one in the general scheme. According to Dr. Swaraj, the traditional management of type 2 diabetes should be revised.
Regarding therapies, he comments that they all have limitations, for example: the ceiling effect of metformin should be remembered (1) and also the side effects and contraindications for glitazones (2). Dr. Swaraj questions many of the diabetes treatment dogmas and presents the case of a patient following the "Swaraj therapy".
Dr. Swaraj concludes his presentation with a brief summary of the therapeutic approach for individual type 2 diabetic patients, putting emphasis on reduction of waist circumference.
Copyright © 2008 E-MedHosting.com Inc.
Learning objectives :
After viewing this presentation the participant will be able to discuss:
- The objectives of type 2 diabetes therapy
- The importance of changes in lifestyle as a treatment option
- Case studies and the use of combination therapy
Bibliographic references :
1- Garber AJ, Duncan TG, Goodman AM, Mills DJ, Rohlf JL.Efficacy of metformin in type II diabetes: results of a double-blind, placebo-controlled, dose-response trial. Am J Med. 1997 Dec;103(6):491-7.
2- Nesto RW, Bell D, Bonow RO, Fonseca V, Grundy SM, Horton ES, Le Winter M, Porte D, Semenkovich CF, Smith S, Young LH, Kahn R.Thiazolidinedione use, fluid retention, and congestive heart failure: a consensus statement from the American Heart Association and American Diabetes Association. Diabetes Care. 2004 Jan;27(1):256-63. Review.
|
|
|
|
|
|
| Search our website |
 |
| |
Would you like to know more about insulin resistance? Are you looking for information pertaining to Type 2 Diabetes? You can find what you are looking for in over 2000 references available on CMEonDiabetes. |
| |
|
|
| Social |
|
| |
Let others know about this presentation.
|
|
|
|
